R&D Expenses
$138.09M
TTM · Period ending: · USD

CLBT R&D Expenses
What is r&d expenses?
Research and development spending.
CLBT r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | R&D Expenses (USD) | Change |
|---|---|---|
| 113,877,000 | +15.71% | |
| 98,415,000 | +16.62% | |
| 84,386,000 | +4.67% | |
| 80,620,000 | +23.01% | |
| 65,541,000 | +20.53% | |
| 54,377,000 | +16.76% | |
| 46,573,000 | — |
Frequently asked questions: CLBT r&d expenses
What is Cellebrite DI Ltd. (CLBT)'s current r&d expenses?
Cellebrite DI Ltd. (CLBT)'s latest reported r&d expenses (TTM) is $138.09M as of Sep 30, 2026. Research and development spending.
How much historical r&d expenses data is available for CLBT?
Stock Alarm Pro provides 7 dated annual fiscal periods observations for Cellebrite DI Ltd. (CLBT)'s r&d expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare CLBT's r&d expenses to peers or set an alert?
You can open CLBT's r&d expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on CLBT delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance